Annual report pursuant to Section 13 and 15(d)

Shareholders' Equity (Details)

v3.22.1
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 2 Months Ended 3 Months Ended 4 Months Ended 5 Months Ended 7 Months Ended 8 Months Ended 12 Months Ended
Oct. 12, 2020
Jul. 31, 2021
Jan. 31, 2022
Oct. 31, 2021
Apr. 30, 2020
Jun. 11, 2021
Jan. 31, 2021
Aug. 27, 2020
Jan. 31, 2022
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock issued             4,000,000       4,000,000  
Number of warrants to purchase additional common shares     705,882           705,882 705,882    
Common shares authorized             1,000,000,000       1,000,000,000  
Preferred shares authorized     10,000,000           10,000,000 10,000,000    
Common stock par value     $ 0.0001       $ 0.01   $ 0.0001 $ 0.0001 $ 0.01  
Common stock shares outstanding             4,000,000       4,000,000  
Fair value adjustment of warrants $ (7,400) $ (17,115) $ (37,164) $ 36,838   $ (900) $ (2,900)   $ (17,441)      
Financial Designation, Predecessor and Successor [Fixed List]         Predecessor Predecessor Predecessor Predecessor Successor Successor Predecessor Predecessor
Class A Common Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock issued     133,258,027       3,840,000   133,258,027 133,258,027 3,840,000  
Common shares authorized     375,000,000       800,000,000   375,000,000 375,000,000 800,000,000  
Common stock par value     $ 0.0001           $ 0.0001 $ 0.0001    
Common stock shares outstanding     133,258,027       3,840,000   133,258,027 133,258,027 3,840,000  
Increase (decrease) in earnings attributable to common stockholders 5,900                      
Class B Common Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock issued             160,000       160,000  
Common shares authorized             200,000,000       200,000,000  
Common stock shares outstanding             160,000       160,000  
Net increase in value of participation rights 13,300                      
Increase (decrease) in earnings attributable to common stockholders $ 5,900                      
Class C Common Stock                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common shares authorized     3,840,000           3,840,000 3,840,000